New drugs for neglected diseases: from pipeline to patients
about
New, improved treatments for Chagas disease: from the R&D pipeline to the patientsFinding cures for tropical diseases: is open source an answer?Designing drugs for parasitic diseases of the developing world.A luciferase based viability assay for ATP detection in 384-well format for high throughput whole cell screening of Trypanosoma brucei brucei bloodstream form strain 427.Research in complex humanitarian emergencies: the Médecins Sans Frontières/Epicentre experience.Drug discovery and development for neglected diseases: the DNDi model.Expert Delphi survey on research and development into drugs for neglected diseasesEstablishment of ATP-based luciferase viability assay in 96-well plate for Trypanosoma congolense.Fostering Canadian drug research and development for neglected tropical diseases.Discovery of safe and orally effective 4-aminoquinaldine analogues as apoptotic inducers with activity against experimental visceral leishmaniasis.Select pyrimidinones inhibit the propagation of the malarial parasite, Plasmodium falciparumPriority review vouchers: an inefficient and dangerous way to promote neglected-disease drug development.Overcoming the challenges of drug discovery for neglected tropical diseases: the A·WOL experience.Neglected diseases prioritized in Brazil under the perspective of metabolomics: A review.Drugs for Neglected Diseases initiative model of drug development for neglected diseases: current status and future challenges.Antitumor quinol PMX464 is a cytocidal anti-trypanosomal inhibitor targeting trypanothione metabolism.Molecular docking of cathepsin L inhibitors in the binding site of papain.The global health crisis and our nation's research universities.Editorial: drug development for neglected diseases: a public health challenge.An ATP-Based Luciferase Viability Assay for Animal African Trypanosomes Using a 96-Well Plate.Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasisThe Neglected Diseases Section in PLoS Medicine: Moving Beyond Tropical Infections
P2860
Q21092295-7A1E19A9-F98E-440C-81D9-2A1989C70D24Q21144737-AF5659F7-E1D3-4DCD-B56C-A072B626F634Q24816910-538082B0-0B2D-4953-8F23-B0E2481BB485Q30883740-A09BECBA-93EC-4E80-AB93-3EAFB67D9B80Q33328627-96C844E2-0C40-4470-8B1B-76F0145F5616Q33892471-47707BCA-76EE-4B48-BF8A-0317D74F42E2Q34075885-7C87B6C7-A0B9-487A-8FD5-01119EBD2C86Q34749735-649274B4-68F2-4BDB-9A4A-9A47E21B9660Q35049882-C21D420D-17ED-41CD-951D-1CF17C1BF34DQ35666558-757CF3D1-6D6F-488A-9036-0DA267A67661Q37417039-FDCC91ED-2365-4075-99FA-5151A3734117Q37487578-B5FE9891-7314-4532-AFC6-59C451FE48F1Q38163392-6ED4BA7B-3A2A-4C33-9B87-DDB5F8958823Q38533526-F3B4074E-D7D9-4997-9E4C-3D53F759B52DQ39712345-6B3D9C6D-40AD-4D87-A97A-8859336E1EFBQ41781992-5B0BEB3F-C8DB-4143-B484-5072F7F3D8F8Q41889166-022DA4A1-B44E-4DB4-AE07-E9EFE8796956Q42909525-C61BD7F2-C563-4187-9EBE-9153CFFEFD50Q44228328-EABD6BA2-43BA-4EDA-BA7A-C210BE3700ACQ46560931-9350CA2B-AA35-419D-A6A2-1C51CBEDDBA3Q57190987-27654EF1-71E6-4725-8748-90844A0D1E93Q57415401-D1FE9D03-7EE9-4C37-91AC-C44848809D4D
P2860
New drugs for neglected diseases: from pipeline to patients
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
New drugs for neglected diseases: from pipeline to patients
@ast
New drugs for neglected diseases: from pipeline to patients
@en
New drugs for neglected diseases: from pipeline to patients
@nl
type
label
New drugs for neglected diseases: from pipeline to patients
@ast
New drugs for neglected diseases: from pipeline to patients
@en
New drugs for neglected diseases: from pipeline to patients
@nl
prefLabel
New drugs for neglected diseases: from pipeline to patients
@ast
New drugs for neglected diseases: from pipeline to patients
@en
New drugs for neglected diseases: from pipeline to patients
@nl
P1433
P1476
New drugs for neglected diseases: from pipeline to patients
@en
P356
10.1371/JOURNAL.PMED.0010006
P407
P577
2004-10-01T00:00:00Z